TSS
ALZN icon

Two Sigma Securities’s Alzamend Neuro ALZN Stock Holding History

Two Sigma Securities’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21
Closed -$6.67K – 2986
2023
Q3 		$6.67K Buy
21
+4
+24% +$1.91K ﹤0.01% 2757
2023
Q2 		$11.5K Buy
17
+4
+31% +$3.13K ﹤0.01% 2577
2023
Q1 		$7.57K Sell
13
-13
-50% -$9.77K ﹤0.01% 2490
2022
Q4 		$19.8K Buy
+26
New +$37.6K ﹤0.01% 2281
2022
Q3 		– Sell
-11
Closed -$13K – 2560
2022
Q2 		$13K Sell
11
-14
-56% -$18.1K ﹤0.01% 2014
2022
Q1 		$42K Buy
25
+2
+9% +$3.76K ﹤0.01% 1896
2021
Q4 		$58K Buy
+23
New +$71.2K ﹤0.01% 1253
2021
Q3 		– Sell
-12
Closed -$140K – 1520
2021
Q2 		$140K Buy
+12
New +$155K ﹤0.01% 1323

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Two Sigma Securities's ALZN Position: Q4 2023 in Review

Two Sigma Securities sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 21 shares — an estimated $6.67K sold.

Two Sigma Securities first reported a position in ALZN in Q2 2021 and held it in 8 quarters. The position peaked at $140K in Q2 2021. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Two Sigma Securities reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 21 Alzamend Neuro shares in Q4 2023, an estimated $6.67K.
  • Two Sigma Securities first reported a position in Alzamend Neuro in Q2 2021 and held it in 8 quarters.
  • Two Sigma Securities's Alzamend Neuro position peaked at $140K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.